Clinical Evaluation of Triticum's Honey-Based Products for Lower Extremity Wounds in a Home Care Setting

Maastricht, Netherlands, July 06, 2011 --(PR.com)-- In this article the author evaluated the honey-based products (L-Mesitran) in a home care setting over a five-year period. In that time 22 cases of lower extremity wounds were treated with L-Mesitran. All retrospectively selected patients were initially treated with povidone iodine or fusidic acid, which resulted in delayed wound healing. Fifty percent of the wounds were infected. Treatment with L-Mesitran resulted in removal of infection and wound healing.

Aims: To evaluate the efficacy of commercially available honey-based products for the treatment of lower extremity wounds in a home care nursing setting.

Methods: Twenty-two patients with lower extremity wounds (six male and 16 female, with an average age of 64 years), were retrospectively selected. Six patients had venous insufficiency, five had diabetes and the remaining patients had hypertension or rheumatoid arthritis as a major underlying aetiology. All the patients had non-healing wounds of at least four weeks’ duration, in which they had been treated primarily with povidone iodine or fusidic acid. Fifty percent of the wounds were infected. All the wounds were treated with honey-based products, and only covered with a secondary dressing for protection or absorption of exudate.

The results of this evaluation indicate that honey-based products are antibacterial, help to debride the wound and promote wound healing, and are safe and easy to use as well as being cost-effective.

###